Mark Reppell
Impact in
- Genetics top 5%
- Inflammatory Bowel Disease
- Genetic Associations and Epidemiology
- Genomics and Rare Diseases
-
- Pharmacogenetics and Drug Metabolism
Papers in
- Genetics 10
- Inflammatory Bowel Disease 5
- Genetic Associations and Epidemiology 2
- Forensic and Genetic Research 2
- Genomics and Rare Diseases 1
-
- Genomics and Phylogenetic Studies 1
- Co-authors
- John Novembre (3 shared papers)Sebastian K. Zöllner (3 shared papers)Michael Boehnke (2 shared papers)Heath Guay (4 shared papers)Pamela L. St. Jean (1 shared paper)Daniel Wegmann (1 shared paper)Valerie L. Pivorunas (3 shared papers)Matthew R. Nelson (1 shared paper)
- Journals
- Journal of Crohn s and Colitis (4 papers)Gastroenterology (1 paper)Genetics (1 paper)Bioinformatics (1 paper)Nature Genetics (1 paper)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
Mark Reppell
14 papers receiving 916 citations
Mark Reppell's Hit Papers
Peers
Comparison fields: 5 of 50
- Genetics 507
- Pharmacology 11
- Immunology 23
- Hematology 16
- Ophthalmology 11
Countries citing papers authored by Mark Reppell
This map shows the geographic impact of Mark Reppell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Reppell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Reppell more than expected).
Fields of papers citing papers by Mark Reppell
This network shows the impact of papers produced by Mark Reppell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Reppell. The network helps show where Mark Reppell may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Reppell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease Hit paper breakdown → | 2019 | 324 |
| 2 | Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank Hit paper breakdown → | 2021 | 270 |
| 3 | Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes Hit paper breakdown → | 2022 | 183 |
| 4 | 2023 | 66 | |
| 5 | 2014 | 18 | |
| 6 | 2018 | 14 | |
| 7 | 2023 | 13 | |
| 8 | 2014 | 10 | |
| 9 | 2024 | 9 | |
| 10 | 2012 | 8 | |
| 11 | 2023 | 6 | |
| 12 | 2025 | 5 | |
| 13 | 2020 | 3 | |
| 14 | 2014 | 1 |
About Mark Reppell
Mark Reppell is a scholar working on Genetics, Molecular Biology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 14 papers that have together received 930 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (5 papers), Genetic Associations and Epidemiology (2 papers), Forensic and Genetic Research (2 papers), Genomics and Rare Diseases (1 paper) and Genomics and Phylogenetic Studies (1 paper). The work is most often cited by research in Genetics (507 citations), Pharmacology (11 citations), Immunology (23 citations), Hematology (16 citations) and Ophthalmology (11 citations). Mark Reppell has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include John Novembre, Sebastian K. Zöllner, Michael Boehnke, Heath Guay, Pamela L. St. Jean, Daniel Wegmann, Valerie L. Pivorunas, Matthew R. Nelson, Margaret G. Ehm and Matthew Zawistowski. Their work appears in journals such as Journal of Crohn s and Colitis, Gastroenterology, Genetics, Bioinformatics and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.